Superior Planning LLC’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12K Buy
+135
New +$13K 0.01% 865

Other funds holding SYRE

Superior Planning LLC's SYRE Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 135 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #865 among its holdings.

220 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.

  • Superior Planning LLC held 135 shares of Spyre Therapeutics worth $12K as of Q3 2026.
  • Spyre Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Spyre Therapeutics made up 0.01% of Superior Planning LLC's portfolio in Q3 2026, its #865 holding.
  • 220 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.